Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Dynacure S.A.S.

Headquarters: Illkirch, France
Year Founded: 2016
Status: Private

BioCentury | Mar 3, 2023
Finance

March 2 Quick Takes: MorphoSys laying off staff, ending preclinical work

Plus: Flamingo teaming up with Dynacure and updates from Debiopharm, Aldeyra, Checkpoint and more
BioCentury | Jan 12, 2023
Management Tracks

Azafaros hires Freitag, promotes Landskroner

Plus: KemPharm promotes Guenther and Mickle, and updates from
BioCentury | Nov 28, 2022
Management Tracks

Biosplice’s Beaupre becomes CMO at Ideaya

Plus: Blaine Davis named CFO at Selecta, and updates from Promontory, ARTHEx and Shionogi
BioCentury | Jul 8, 2022
Deals

July 8 Quick Takes: ADC out-licenses Zynlonta to Sobi in Europe; MacroGenics closes study

Plus Dynacure ends DYN-101 trial and updates from Radius, Exelixis
BioCentury | Dec 7, 2021
Management Tracks

Biohaven names Coric chair, Buten CFO

Plus: Mutamba joins Arrakis as CBO and updates from Goldfinch, Kymera, AnHeart and more
BioCentury | Jul 17, 2021
Regulation

New NASDAQ listings see mixed performance

Erasca, Imago posted single-digit gains, while TScan shed nearly a third of its value
BioCentury | May 5, 2021
Finance

Europe’s top venture fund-raisers in 2018-20: Data Byte

At least six European biotechs raised more than $100 million in 2018-20 and are still private, with Oxford Nanopore Technologies Ltd. topping the list at $314.6 million.  A further four companies
BioCentury | May 4, 2021
Management Tracks

Guardant unveils Eagle as CMO; plus Karyopharm, Arix, Eagle, Gemini, Neoleukin, MEI, Krystal, Relay and more

Cancer diagnostics company Guardant Health Inc. (NASDAQ:GH) hired Craig Eagle as CMO. Eagle, who was most recently was VP of medical affairs oncology at Genentech Inc., is a 19-year veteran of
Items per page:
1 - 10 of 25